Next Event in Series
Translating Novel Radiopharmaceutical Therapies to Transform the Medical Future
10-12 November, 2025 | Amsterdam, Netherlands
Future Events in Series
Accelerating Your Radiopharmaceutical Production & Supply Capabilities
September 23-25, 2025 | Boston, MA
Maximizing the Future of Radiopharmaceuticals Through Novel Targets, Next Generation Ligands & Translating Bench to Bedside Clinical Performance Through Quantitative Imaging & Robust Isotope Supply
There is no denying the targeted radiopharmaceuticals (TRP) sector is gaining significant momentum and shows no signs of slowing. AtomVie Global Radiopharma and TerraPower Isotopes recently announced a strategic supply agreement for Actinium-225 to support the development and manufacturing of TRP therapeutics. This follows a $1.3 billion licensing deal for OncoACP3 and a new Gadolinium-160 supply partnership between ASP Isotopes and Isotopia.
These milestones underscore the rapid advancement of precision radiopharmaceuticals: validated tumor-targeting therapies are entering clinical stages, isotope supply chain collaborations are strengthening, and the global TRP market is projected to triple by 2031.
As demand surges, the opportunity to shape the future of precision oncology and nuclear medicine has never been greater. However, key challenges remain, ranging from R&D and clinical translation to manufacturing scale-up and regulatory navigation.
The 4th Targeted Radiopharmaceuticals Summit US returned to San Diego, uniting 275+ global stakeholders from biotech, pharma, and academia, to tackle these challenges head on. Leading organizations including Novartis, AstraZeneca, Bristol Myers Squibb, Ratio Therapeutics, Alpha-9 Oncology, AdvanCell, Mariana Oncology, and Abdera Therapeutics all committed to advancing their pipeline and registered their place.
As the industry’s premier end-to-end platform, the summit was solely dedicated to accelerating the development and delivery of next-generation TRP therapeutics to capitalize on the potential of nuclear medicine. Across 3 days jam-packed with content across three focused tracks, we explored cutting-edge targeting molecules, enhancing clinical translational success, and overcoming isotope supply constraints.
Cross discipline engagement in an intimate setting. Lots of opportunities to connect across the industry more effectively than a large and less bespoke conference.
Networking, intimate setting, valuable conversations and interactions with partners in the field. Content was diverse and informative.
Explore the 2025 Full Event Guide
- 50+ World-Class TRP Speakers
- 3 Days of Exclusive, Data-Driven TRP Content
- Unmatched Networking & Strategic Partnering Opportunities
- Focused Industry-Led Community of Top Radiopharmaceutical Biopharma
Speakers - 2025
Official Partners - 2025
Lead Partner
Expertise Partner
Program Partners
Innovation Partners
Attending Companies Included
Explore the 2025 Agenda
Hear the latest industry-led breakthroughs and gain exclusive insights on radiopharmaceutical innovations during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
As the field rapidly expands, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice amid growing competition.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.